Literature DB >> 1312543

Mineralocorticoid effector mechanism in preeclampsia.

D Armanini1, C M Zennaro, L Martella, M Scali, C Pratesi, P V Grella, F Mantero.   

Abstract

Mineralocorticoid effector mechanisms were evaluated in 29 patients with preeclampsia and in 25 uncomplicated pregnancies by measurement of plasma aldosterone, levels of mineralocorticoid receptor (MR) in mononuclear leucocytes, and subtraction potential difference (SPD; rectal minus oral values). Mean values for plasma aldosterone were not different between the two groups, but significant differences were observed for MR (preeclampsia, 81 +/- 44 receptors/cell; controls, 306 +/- 168) and SPD (preeclampsia, 65 +/- 7 mV; controls, 12 +/- 5 mV). In six cases we determined MR, plasma aldosterone, and SPD in patients with preeclampsia before and 3 months after delivery. MR were reduced before delivery (96 +/- 27 receptors/cell), and SPD increased (64 +/- 8 mV), with both parameters normalizing after delivery (MR, 242 +/- 79; SPD, 14.0 +/- 4 mV). Aldosterone levels returned to normal nonpregnant values after delivery. These data suggest an important role for abnormalities in mineralocorticoid effector mechanisms in the etiology of preeclampsia and could be an useful marker for diagnosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312543     DOI: 10.1210/jcem.74.4.1312543

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Hypertensive cardiomegaly caused by an aldosterone-secreting adenoma in a newborn.

Authors:  G B Pozzan; D Armanini; G Cecchetto; G Opocher; F Rigon; A Fassina; F Zacchello
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

2.  Hypertension in pregnancy: Role of body mass index, insulin resistance, aldosterone, and calcium homeostasis.

Authors:  Decio Armanini; Alessandra Andrisani; Guido Ambrosini; Gabriella Donà; Luciana Bordin; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-16       Impact factor: 3.738

3.  Relationship between sodium, pentraxin-3 and aldosterone in inflammation and cardiovascular risk.

Authors:  Decio Armanini; Luciana Bordin; Gabriella Donà; Raffaele Pezzani; Alessandra Andrisani; Guido Ambrosini; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-27       Impact factor: 3.738

4.  Hypothesis on a relationship between hyperaldosteronism, inflammation, somatic mutations, and autoimmunity.

Authors:  Decio Armanini; Alessandra Andrisani; Gabriella Donà; Luciana Bordin; Guido Ambrosini; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-08-20       Impact factor: 3.738

5.  Maternal and Fetal Outcomes in Preeclampsia: Interrelations Between Insulin Resistance, Aldosterone, Metabolic Syndrome, and Polycystic Ovary Syndrome.

Authors:  Decio Armanini; Chiara Sabbadin; Gabriella Donà; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-14       Impact factor: 3.738

6.  Microalbuminuria and hypertension in pregnancy: role of aldosterone and inflammation.

Authors:  Decio Armanini; Guido Ambrosini; Chiara Sabbadin; Gabriella Donà; Giulio Clari; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-05-31       Impact factor: 3.738

Review 7.  Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy.

Authors:  Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin; Gabriella Donà; Jacopo Manso; Filippo Ceccato; Carla Scaroni; Decio Armanini
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-23       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.